Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The spreading of pathology within and between brain areas is a hallmark of neurodegenerative disorders. In patients with Alzheimer’s disease, deposition of amyloid-β is accompanied by activation of the innate immune system and involves inflammasome-dependent formation of ASC specks in microglia. ASC specks released by microglia bind rapidly to amyloid-β and increase the formation of amyloid-β oligomers and aggregates, acting as an inflammation-driven cross-seed for amyloid-β pathology. Here we show that intrahippocampal injection of ASC specks resulted in spreading of amyloid-β pathology in transgenic double-mutant APPSwePSEN1dE9 mice. By contrast, homogenates from brains of APPSwePSEN1dE9 mice failed to induce seeding and spreading of amyloid-β pathology in ASC-deficient APPSwePSEN1dE9 mice. Moreover, co-application of an anti-ASC antibody blocked the increase in amyloid-β pathology in APPSwePSEN1dE9 mice. These findings support the concept that inflammasome activation is connected to seeding and spreading of amyloid-β pathology in patients with Alzheimer’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1 beta was shown to exacerbate tau pathologies [97] and reduce microglial phagocytic activity [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“Rat research has identified the NLRP3-ASC inflammasome as a major mechanism through which microglia may drive pathological features of AD [92,93,94].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [94]
In the citing paper
“In turn, the NLRP3 inflammasome is essential for the development and progression of Aβ pathology in mice29 and may drive tau pathology through Aβ-induced microglial activation30.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [29]
In the citing paper
“Pyroptosis of glial cells leads to release of ASC specks into the extracellular space, where it binds rapidly to Aβ peptides, increasing the aggregation of Aβ.357”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [357]
In the citing paper
“In that study, ASC-bound Aβ was detected in brain samples from AD patients, but not in samples from age-matched controls without dementia.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [80]
23 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citationScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Self-citationUnified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Lu, A., Magupalli, V. G., Ruan, J., Yin, Q., Atianand, M. K., Vos, M. R., Schröder, G. F., Fitzgerald, K. A., Wu, H., & Egelman, E. H. (2014) · Cell · doi:10.1016/j.cell.2014.02.008 · Cited by 1,353
Cited by
Items 801–900 of 1,002
Sánchez, K. E., Jiang, S., Desai, S. P., Thompson, J., Hobson, S., Rosenberg, G. A., & Bhaskar, K. (2024) · STAR Protocols · doi:10.1016/j.xpro.2024.102916 · Cited by 2
Hushmandi, K., Reiter, R. J., Farahani, N., Cho, W. C. S., Alimohammadi, M., & Khoshnazar, S. M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111325 · Cited by 2
Periodontal disease and brain amyloid pathology in mild cognitive impairment
Gil-Montoya, J. A., Gerez-Muñoz, M. J., Triviño‐Ibáñez, E. M., Carrera-Muñoz, I., Bravo, M., Rashki, M., Solis‐Urra, P., Esteban‐Cornejo, I., & Gómez-Río, M. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.07.008 · Cited by 6
Li, T., Castro‐Gomez, S., Lucena, P. B., Vieira-Saecker, A. M. M., Schwartz, S., Ding, Y., Deng, Y., Gou, M., Stein, V., Golenbock, D. T., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199818 · Cited by 3
“…have been observed in several neurodegenerative disorders characterized by sustained, chronic low-grade neuroinflammation (71), such as Alzheimer’s and Parkinson’s disease, in which ASC plays a decisive role in the aggregating and further propagating amyloid β (61) and α -synuclein (72).”
Self-citationInflammasome protein seeds plaques in Alzheimer disease
Cully, M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.5 · Cited by 2
Kemal, S., & Vassar, R. J. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20191536 · Cited by 3
“On the other hand, sustained microglial activation has been shown to result in a chronic pro-inflammatory state that is detrimental to neuronal survival and even causative in the spread of Aβ and tau (Venegas et al., 2017; Asai et al., 2015).”
BackgroundCommunity Mediation Service: A Model for Teaching Democracy and Conflict Resolution.
Slaton, C. D. (1994) · Cited by 2
Protective Effects of Cannabis in Neuroinflammation-Mediated Alzheimer's Disease
Kashif, M., Waseem, M., Vijendra, P. D., & Pandurangan, A. K. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch002 · Cited by 2
Human IL-34 Deficiency Primes Microglia Toward Alzheimer’s Disease-Associated StatesPreprint
Hernández-Rasco, F., Ruiz, R. R., de Rojas, I., Puerta, R., Garcia-Mayor, C., Espinosa‐Oliva, A. M., García‐Revilla, J., Bayón-Buján, P., Rivera-Ramos, A., Oualit, F. R., et al. (2026) · medRxiv · doi:10.64898/2026.02.21.26346696 · Cited by 3
Self-citationMakoni, N. J., Garrad, E. C., Redzic, A., & Nichols, M. R. (2021) · Biotechnology Progress · doi:10.1002/btpr.3153 · Cited by 1
“Additional studies demonstrated that the K21A mutation in the ASC PYD made the protein highly resistant to oligomerization.(13,15,16,20) ASC aggregation, or speck formation, was also demonstrated by HeLa cell expression of ASC-yellow fluorescent protein.”
BackgroundAstillero‐Lopez, V., Villar‐Conde, S., González-Rodríguez, M., Flores‐Cuadrado, A., Úbeda‐Bañón, I., Saiz‐Sánchez, D., & Martínez-Marcos, A. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.08.680 · Cited by 1
Tracing inflammasomes in Alzheimer’s: insights from bibliometric analysis
Chen, Y., Pei, H., Li, H., Zeng, W., & Li, Z. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1540083 · Cited by 1
“Four studies explore the relationship between the NLRP3 inflammasome and the pathological deposition of amyloid-beta and tau proteins, noting that it can be activated by these proteins and accelerate their accumulation (10, 11, 14, 17).”
Proteasome-mediated ubiquitination in neural regeneration
Li, H., Hu, Y., Cheng, M., Wang, J., Zhao, M., Cao, B., Zhao, Y., & Jiang, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118563 · Cited by 1
Mapping microglial mechanisms in Alzheimer’s disease: a comprehensive analysis
Wang, X., Guo, Y., Zha, Y., Wang, S., Yang, W., & Jia, Q. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10808 · Cited by 1
“Furthermore, in fl ammasome-activated microglia release ASC specks that bind to A β , promoting its aggregation and spread, thereby intensifying amyloid pathology [23].”
Evaluation of ASC as a therapeutic target for Alzheimer's disease
Clayton, B., Kulas, J. A., Liu, J., Walia, N., Rangel‐Barajas, C., Johnson, T. S., Zhang, J., Huang, K., Mesecar, A. D., Dage, J. L., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71104 · Cited by 1
Zeng, Y., Xu, D., Li, X., Jiang, Q., & Liang, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1744898 · Cited by 2
“In contrast, the release of damage-associated molecular patterns (DAMPs) by apoptotic cells serves to exacerbate microglial TLR4/NF-κ B signalling, thereby amplifying NLRP3 inflammasome activation (Venegas et al., 2017).”
Role of NLRP3 Inflammasome in Neurodegeneration and Cancer: A Double-Edged Sword
Do, E., & Hansda, S. (2026) · Onco · doi:10.3390/onco6010012 · Cited by 1
“Thus, NLRP3 activation is not just a response to plaques, but a primary driver of their formation and subsequent spreading [50].”
Microglial Senescence in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives
Liu, Y., Hu, Z., Xiao, Y., Han, X., Cheng, X., & Ye, T. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00016 · Cited by 1
IL-18 binding protein attenuates neuroinflammation and cognitive decline in Alzheimer’s disease
Hong, D. K., Jeon, S. H., Kang, M., Lee, S., Liu, X., Ahn, E. H., & Kang, S. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03720-7 · Cited by 2
“In AD, pathological hallmarks such as amyloid-β (Aβ) plaques and Tau tangles trigger NLRP3 inflammasome activation in microglia, the brain’s primary immune cells [20, 21].”
Gu, L., Liu, J., Shan, X., Li, S., Zheng, M., Wang, C., Tan, Y., Zhuo, X., Li, Q., Yang, W., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158028 · Cited by 1
Zhu, X., Lai, X., Deng, J., & Long, Y. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115728 · Cited by 1
Long, S., Li, R., Yang, J., Cheng, R., Wang, Y., & Dong, Y. (2026) · Cytotechnology · doi:10.1007/s10616-026-00952-6 · Cited by 2
“However, the maturation and release of IL-1β in microglia are due to NLRP3 inflammasome activation (Lučiūnaitė et al. 2020 ; Venegas et al. 2017).”
Sandhu, J. K., Tanha, J., & Arbabi‐Ghahroudi, M. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2671675 · Cited by 2
Peripheral biomarkers of neuroinflammation in Alzheimer’s disease and vascular dementia
Ouyang, X., Chia, R. S. L., Chai, Y. L., Chong, Sim, M. A., Jo, D., Arumugam, T. V., Sethi, G., Dawe, G. S., Chen, C. P., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118077 · Cited by 3
Hospital-treated infection associated with Alzheimer’s disease pathology: underlying mechanisms
Barichello, T., Scaini, G., Tayyab, M., Dal-Pizzol, H. R., Petronilho, F. C., & Dal‐Pizzol, F. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03690-5 · Cited by 1
“2 [47, 50, 54].”
InfluentialZhang, J., Yang, N., Zou, P., & Zong, X. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03924-x · Cited by 2
“The inflammation/complement axis includes chronic NLRP3 activation, inflammasome-driven tau hyperphosphorylation [35], ASC-speck cross-seeding of Aβ [36], and C1q/C3-dependent synaptic engulfment that mediates pre-plaque synapse loss in AD models [37, 38].”
Tang, S., Geng, Y., Lin, Q., & Tian, Z. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06039-9 · Cited by 1
“…of large amounts of pro-inflammatory mediators and oxidative stress products, which in turn result in neuronal cell death, synaptic dysfunction, BBB disruption, inhibition of neural stem cell proliferation, and impaired neural network remodeling, ultimately contributing to neurodegeneration [6, 7].”
Mechanism and regulation of programmed cell death in aging-related diseases
Xie, X., & Xu, D. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.06.005 · Cited by 1
Waseem, A., Ghosh, S., Kumari, M., Raza, S. S., & Verma, S. K. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103257 · Cited by 1
Zou, Y., Ou, Y., Zhao, H., Chen, G., Chen, Z., Li, Y., & Jiang, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119841 · Cited by 1
Yaduvanshi, D., Aggarwal, R., Sameeya, A., Aqil, M., Mujeeb, M., Akhtar, M., & Najmi, A. K. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2723488 · Cited by 1
“This starts a cycle of composite forms and the NLRP3 activity that makes it harder for micro-glial cells to get rid of the plaque residues and speeds up the AD progression (Figure 2) [32–34].”
Bellver‐Sanchís, A., Ralchev, N., Romanska, P. R., Dyakova, N. K., Ivanova, K. I., Griñán‐Ferré, C., & Marchev, A. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177833 · Cited by 1
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_3 · Cited by 1
Age-Linked Non-Transmissible Diseases
Swynghedauw, B. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-15111-9_6 · Cited by 1
How Repair-or-Dispose Decisions Under Stress Can Initiate Disease Progression
Nold, A., Batulin, D., Birkner, K., Bittner, S., & Tchumatchenko, T. (2020) · iScience · doi:10.1016/j.isci.2020.101701 · Cited by 2
Brandys, N., & Chadzińska, M. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2021-0014 · Cited by 2
Microglia and border-associated macrophages in the central nervous system
Zanluqui, N. G., Polonio, C. M., de Oliveira, M. G., de Oliveira, L. G., Faria, L. C., & Peron, J. P. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821385-8.00013-5 · Cited by 1
Inflammasome and neurodegenerative diseases
Ravichandran, K. A., & Heneka, M. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00029-3 · Cited by 1
Self-citationParkinson- und Alzheimer-Erkrankung als Systemerkrankungen
Bartsch, T., Berg, D., Heneka, M. T., & Leypoldt, F. (2023) · Der Nervenarzt · doi:10.1007/s00115-023-01542-z · Cited by 2
Self-citationMicroglia cannibalism during neurodevelopment results in necroptotic cell death
Bennett, F. C., & Bennett, M. L. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002869 · Cited by 1
Forgham, H., Albornoz, E. A., Pietrogrande, G., Munir, M. U., Zhu, J., Anjum, M. A., Chung, K. H. K., Tahir, M. S., Ali, S. A., Käkinen, A., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00122-7 · Cited by 1
“61 In brain organoids, we further observed clustering of BAS with A β , colocalization within microglia accompanied by an activated microglia phenotype (CD68-positive microglia).”
Villamil-Ortiz, J. G. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.99684546 · Cited by 1
Reframing the Question: Does Mitochondrial Damage Set the Stage for Future Inflammation?
Pascual, F. L. (2021) · Environmental Health Perspectives · doi:10.1289/ehp9598 · Cited by 1
Investigating a Mechanistic Link between Mindful Music-Listening and Regulation of NeuroinflammationPreprint
Page, N., & Loui, P. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/7sde5 · Cited by 1
Lee, C. Y. D., Rocha, A. J. D. L., Inouye, K., Langfelder, P., Daggett, A., Gu, X., Jiang, L.-L., Pamonag, Z., Vaca, R., Richman, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.03.551881 · Cited by 1
“Cruising together”—ASC specks and SAA, a perfect match in chronic inflammation
Maasewerd, S., & Franklin, B. S. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00109-y · Cited by 1
“The second hypothesis gained strength in 2017, with the discovery that eASC accelerated amyloid-β deposition in Alzheimer ’ s disease (Venegas et al, 2017), another amyloid precursor that shares large similarities to AA.”
BackgroundSelf-citationDysfunctional K+ Homeostasis as a Driver for Brain Inflammation
Ozsoy, N., & Dallas, M. L. (2024) · Encyclopedia · doi:10.3390/encyclopedia4040110 · Cited by 1
“For instance, considerable evidence from Alzheimer’s disease (AD) research reveals that microglial inflammation is a critical factor in disease onset and progression, thus establishing it as a valuable target for investigating disease mechanisms [20].”
Wang, W., Zhao, L., & Whitehead, S. N. (2025) · Research Square · doi:10.21203/rs.3.rs-6939497/v1 · Cited by 1
Lam, S. (2021) · theses.fr (ABES) · doi:10.70675/60b353ffz56fcz41a2z9e53zf0d9ac078167 · Cited by 1
ASC-Specks: Kristallisationskeime der Alzheimer-Erkrankung
Hermann, D. M. (2018) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-018-2606-x
Sokolik, V. V., Sokolik, V. V., & 46, A. P. S. (2018) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs03.04.206
Differenzialdiagnose und Therapie akuter Enzephalopathien
Hansen, H.-C. (2018) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-018-2446-8
Gelpí, E., Klotz, S., Lang, A., Stögmann, E., & Kovács, G. G. (2019) · Clinical Neuropathology · doi:10.5414/np301175
“At the same time, the release of cytokines and other inflammatory mediators by microglia contributes to Aβ oligomerisation, crossseeding and aggregation [11], and to synaptic damage.”
Family of protein fragments promises fresh view of Alzheimer's disease
Schubert, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905886116
Groslambert, M. (2019) · theses.fr (ABES) · doi:10.70675/7ec36fdaz7c33z4ac3z8f3azf6a7d1320f06
Role of NLRP3 inflammasome activation in the pyroptotic cell death of glial cells
황보름 (2019) · YUHSpace (Yonsei University Medical Library)
Lindgrén, N. (2021) · UTUPub (University of Turku) · Cited by 2
ENERGY DISTRIBUTION OF SHOCKS CREATED BY PARTICLES DISPLACED BY IRRADIATION INSIDE AN ALLOY.
Joyes, P. (1967) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
A sesenta y cinco años de "El Malestar en la Civilización", de Sigmund Freud
Quintana, A. C. (2004) · Dialnet (Universidad de la Rioja)
Marugán, F. F. (1998) · Sistema: Revista de ciencias sociales
Anchoring of Amyloid-β onto Polyunsaturated Phospholipid Membranes
Yuan, R., & Huang, H. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2016488
“This intriguing result is not consistent with some previous results in which the Ab(25-35) inserts deeper into omega-3 membranes (Ermilova & Lyubartsev, 2020; Vitiello et al., 2013).”
ResultFaculty Opinions recommendation of The link between chronic pain and Alzheimer's disease.
Bergese, S. D., & Echeverria-Villalobos, M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736867128.793567607
Critical Roles of Glial Neuroinflammation in Age-Related Memory Decline
Hisatsune, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_17
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00002-x
Sancho, M., Soriano‐Teruel, P. M., & Orzáez, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00038-4
Timmerman, R. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1603
Wei, J., Hu, L., Xu, S., Li, Y., Liao, F., Zhang, X., Fang, X., Ding, L., Wang, T., Chen, Z., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2348942/v1
A neuroinflamação da Doença de Alzheimer e sua correlação anatômica
Netto, F. D. F., Santos, A. A., Gesser, G. T., Perreto, L., Pironatto, M. L. D. M., Andreassa, P. S., & Batista, T. Y. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n1-133 · Cited by 1
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez, E., Laurent, C. D. S., Cortez, L. M., Patel, Z. H., Sidhu, G., Sarkar, S., Aghanya, V., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3147035/v1
Alzheimer’s disease beyond the amyloid accumulation
Urkon, M., & Nagy, E. E. (2022) · Orvostudományi Értesítö · doi:10.2478/orvtudert-2022-0002
Treating Alzheimer’s and ATTR using CRISPR-Cas9 to target amyloidosis
Joshi, P., Guilz, N. C., & Amendola, M. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i3.4806
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151181
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151178
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151166
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151172
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151169
Lin, W., Zhao, L., Liang, G., Zhou, R., Zheng, X., Tao, R., Huo, Q., Su, C.-F., Li, M., Xu, N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612913
Overview of Mechanisms Underlying Neuroimmune Diseases
Sonar, S. A., & Lal, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-24297-7_1-1
Neurovirology and Brain Health—A Microglial Perspective
Biswas, A. K., & Sarma, J. D. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_7
Cellular biology of the central nervous system
Leyendecker, J., Prasse, T., Karp, A., & Khaing, Z. Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95730-4.00016-0
Prodrugs for neurodegenerative diseases
Guglielmi, P., Granese, A., Secci, D., & Chimenti, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15635-9.00011-0 · Cited by 1
Coudereau, R. (2023) · theses.fr (ABES) · doi:10.70675/d8dd405fz1435z4d72z9191z26e62d4202f9
Overview of Mechanisms Underlying Neuroimmune Diseases
Sonar, S. A., & Lal, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_1
Zheng, J., Wang, J., Chen, L., Jiang, X., Zhang, X., Ai, W., Xie, Y., Wang, P., Lan, Z., & Ding, X. (2024) · Journal of Natural Medicines · doi:10.1007/s11418-024-01861-8
Understanding Alzheimer’s Disease: A Multidisciplinary Perspective
Akbarzadehmoallemkoalei, M., Yektakasmaei, M. P., Tabar, S. S. S., Zolfaghari, K., Noorikoloori, S., Niktalab, P., Rouzrokh, S., Sheykhzadeh, Z., Sanavi, M. A., Dozdouzan, M. A., et al. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_14 · Cited by 1
Digestive exophagy as a novel mechanism of amyloid-β degradation by microglial lysosomes
Meyer‐Luehmann, M. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.01.005
Bioinformatic Analysis of Alzheimer’s Disease Metabolomic Datasets for Ceramides and Gangliosides
Rodríguez, S. C. A., Cajuste, S., Waghwala, S., & Bhattacharya, S. K. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4534-5_27
Bilder, G. E., & Brown-O’Hara, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-84831-5_4
Connecting Link Between Dysbiotic Microbiota and Alzheimer’s Disease: Role of Phytochemicals
Kumari, S., Verma, H., Gangwar, P., Yadav, A., Yadav, B., Rao, R., Mantha, A. K., & Dhiman, M. (2025) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-031-80973-6_20
Bakkar, N. Z., Arida, R. E., Soliman, A. Y., & EL‐Yazbi, A. F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-32852-7.00016-4 · Cited by 2
Formaldehyde, Neuroinflammation, and Cognitive Impairment
Kang, N., Liu, Y., & He, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-7281-3_12
Mechanisms of Neuronal Damage and Dysfunction
Ansari, U. A. (2025) · Springer eBooks · doi:10.1007/978-981-95-0125-0_1 · Cited by 1
Berezin, A. Е., & Berezin, O. O. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf204
Parkinson's disease, herpes simplex virus type 1, and nanopore sequencing: A case analysis
Wang, Z., Wang, H., Su, X., Mao, J., Zhou, S., Zhang, Y., Ying, X., Wei, C., & Duan, S. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102310
“At the molecular level, WES identified key mutations clustered within two core pathways: mitochondrial dysfunction and immune dysregulation [32,33].”
Raich, L., Könken, M., Grochowska, K. M., Puig, B., Mayer, C., Hadjilaou, A., Schlemm, E., Shafiq, M., Thomalla, G., Magnus, T. U., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.27.690912
“Myeloid cell activation is a well-established contributor to AD pathogenesis 5,40–42 , as well as interferon-245 driven responses which have also been implicated in neuronal injury and neurodegeneration in AD 43 and across neuroinflammatory and neurodegenerative disorders 44,45 .”
Liu, X.-Y., Yuan, J.-X., Wu, C., Liu, Q., Ding, Q., Zhang, C.-L., Lan, Y., & Xu, G. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150105
Metadata
- Authors
- Venegas, C., Kumar, S., Franklin, B. S., Dierkes, T., Brinkschulte, R., Tejera, D., Vieira-Saecker, A., Schwartz, S., Santarelli, F., Kummer, M. P., Griep, A., Gelpi, E., Beilharz, M., Riedel, D., Golenbock, D. T., Geyer, M., Walter, J., Latz, E., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Heneka, Michael T.
- ORCID
- Venue
- Nature
- Published
- 2017-12
- Volume
- 552
- Issue
- 7685
- Pages
- 355-361
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2777928756
- Semantic Scholar
- cb17ef0ab08a09442fa73b451fad4635f8d4ab3b
- Cited by
- 983
- References
- 33
- Citations by year
- 2026: 90 · 2025: 112 · 2024: 135 · 2023: 129 · 2022: 130 · 2021: 129 · 2020: 108 · 2019: 81 · 2018: 64 · 2017: 1
- FWCI
- 51.62
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, ASC specks, microglia, inflammasome, cross-seeding, amyloid-beta oligomers, innate immunity, neuroinflammation, amyloid-beta aggregation
- MeSH terms
- Protein Domains, Alzheimer Disease, Animals, Antibodies, Female, Hippocampus, Humans, Inflammation, Mice, Inbred C57BL, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Microglia, Mice, Knockout, Mice, CARD Signaling Adaptor Proteins, Presenilin-1, Inflammasomes, Spatial Memory, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.